Wolfhard Engel

1.9k total citations
18 papers, 1.6k citations indexed

About

Wolfhard Engel is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Wolfhard Engel has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 7 papers in Organic Chemistry. Recurrent topics in Wolfhard Engel's work include Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (7 papers) and Chemical Synthesis and Analysis (4 papers). Wolfhard Engel is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (7 papers) and Chemical Synthesis and Analysis (4 papers). Wolfhard Engel collaborates with scholars based in Germany, Switzerland and United States. Wolfhard Engel's co-authors include Wolfgang Eberlein, Henri Doods, K Rudolf, Michael Entzeroth, H. Wieland, Dongmei Wu, Wolfgang Wienen, G. Trummlitz, Peter Luger and Klaus Wagner and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

Wolfhard Engel

18 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfhard Engel Germany 15 917 733 330 232 221 18 1.6k
John M. Schaus United States 24 639 0.7× 505 0.7× 210 0.6× 150 0.6× 366 1.7× 50 1.6k
Wolfgang Eberlein Germany 20 1.4k 1.5× 1.1k 1.4× 345 1.0× 280 1.2× 136 0.6× 27 2.0k
Margaret S. Beer United Kingdom 24 879 1.0× 997 1.4× 221 0.7× 162 0.7× 481 2.2× 53 1.8k
Cen Xu United States 22 775 0.8× 615 0.8× 797 2.4× 185 0.8× 263 1.2× 52 1.9k
David O. Calligaro United States 28 1.2k 1.3× 1.2k 1.7× 507 1.5× 400 1.7× 260 1.2× 75 2.4k
Krystyna M. Wozniak United States 28 1.2k 1.3× 1.0k 1.4× 145 0.4× 363 1.6× 185 0.8× 70 2.5k
Anton D. Michel United Kingdom 28 917 1.0× 1.3k 1.8× 221 0.7× 594 2.6× 261 1.2× 55 2.6k
Joseph F. Gardocki United States 18 529 0.6× 454 0.6× 619 1.9× 190 0.8× 417 1.9× 30 1.8k
C. Guérémy France 25 1.7k 1.9× 1.3k 1.7× 177 0.5× 216 0.9× 342 1.5× 51 2.6k
Stefanie A. Kane United States 33 1.1k 1.2× 1.1k 1.5× 1.1k 3.3× 686 3.0× 357 1.6× 63 3.1k

Countries citing papers authored by Wolfhard Engel

Since Specialization
Citations

This map shows the geographic impact of Wolfhard Engel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfhard Engel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfhard Engel more than expected).

Fields of papers citing papers by Wolfhard Engel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfhard Engel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfhard Engel. The network helps show where Wolfhard Engel may publish in the future.

Co-authorship network of co-authors of Wolfhard Engel

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfhard Engel. A scholar is included among the top collaborators of Wolfhard Engel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfhard Engel. Wolfhard Engel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Doods, Henri, Dongmei Wu, Michael Entzeroth, et al.. (2000). Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. British Journal of Pharmacology. 129(3). 420–423. 386 indexed citations
3.
Wu, Dongmei, et al.. (2000). Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)2,7]hCGRP-preferring receptor. European Journal of Pharmacology. 400(2-3). 313–319. 47 indexed citations
4.
Doods, Henri, Wolfram Gaida, H. Wieland, et al.. (1999). BIIE0246: A selective and high affinity neuropeptide Y Y2 receptor antagonist. European Journal of Pharmacology. 384(2-3). R3–R5. 170 indexed citations
5.
Miao, Clara K., Charles L. Cywin, Ronald Sorcek, et al.. (1997). Effect of Structural Modification of Enol−Carboxamide-Type Nonsteroidal Antiinflammatory Drugs on COX-2/COX-1 Selectivity. Journal of Medicinal Chemistry. 40(6). 980–989. 74 indexed citations
6.
Doods, Henri, H. Wieland, Wolfhard Engel, et al.. (1996). BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: A review of its pharmacological properties. Regulatory Peptides. 65(1). 71–77. 112 indexed citations
7.
Luger, Peter, et al.. (1996). Structure and physicochemical properties of meloxicam, a new NSAID. European Journal of Pharmaceutical Sciences. 4(3). 175–187. 202 indexed citations
8.
Entzeroth, Michael, Wolfgang Eberlein, Wolfhard Engel, et al.. (1995). Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226. European Journal of Pharmacology. 278(3). 239–242. 32 indexed citations
9.
Rudolf, K, Wolfgang Eberlein, Wolfhard Engel, et al.. (1994). The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. European Journal of Pharmacology. 271(2-3). R11–R13. 337 indexed citations
10.
Doods, Henri, Michael Entzeroth, G.B. Schiavi, et al.. (1993). Characterization of BIBN 99: A lipophilic and selective muscarinic M2 receptor antagonist. European Journal of Pharmacology. 242(1). 23–30. 29 indexed citations
11.
Engel, Wolfhard, et al.. (1989). Tricyclic compounds as selective muscarinic receptor antagonists. 3. Structure-selectivity relationships in a series of cardioselective (M2) antimuscarinics. Journal of Medicinal Chemistry. 32(8). 1718–1724. 34 indexed citations
12.
Eberlein, Wolfgang, et al.. (1988). Tricyclic compounds as selective antimuscarinics. 2. Structure-activity relationships of M1-selective antimuscarinics related to pirenzepine. Journal of Medicinal Chemistry. 31(6). 1169–1174. 25 indexed citations
13.
14.
Engel, Wolfhard, Ian Fleming, & R. H. SMITHERS. (1986). Effect of a β-silyl group on the regiochemistry of enolisation of ketones. Journal of the Chemical Society Perkin Transactions 1. 1637–1641. 13 indexed citations
15.
Engel, Wolfhard, et al.. (1971). Isochinoline, II. 3.3‐Dialkylsubstituierte 3.4‐Dihydro‐isochinoline aus Alkyl‐aryl‐cyclopropanen. Chemische Berichte. 104(1). 248–258. 6 indexed citations
16.
Engel, Wolfhard, et al.. (1970). Isochinoline,1. Synthese 3.3‐dialkylsubstituierter 3.4‐Dihydro‐ und 1.2.3.4‐Tetrahydro‐isochinoline. Chemische Berichte. 103(6). 1674–1691. 11 indexed citations
17.
Criegee, Rudolf, et al.. (1963). Valenzisomere des Octamethylcyclooctatetraens. Chemische Berichte. 96(8). 2230–2237. 20 indexed citations
18.
Criegee, Rudolf, et al.. (1963). Einige weitere Umsetzungen des 3.4‐Dichlor‐1.2.3.4‐tetramethyl‐cyclobutens. Chemische Berichte. 96(9). 2362–2367. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John M. Schaus Breakdown of academic impact, for papers by Wolfgang Eberlein Breakdown of academic impact, for papers by Margaret S. Beer Breakdown of academic impact, for papers by Cen Xu Breakdown of academic impact, for papers by David O. Calligaro Breakdown of academic impact, for papers by Krystyna M. Wozniak Breakdown of academic impact, for papers by Anton D. Michel Breakdown of academic impact, for papers by Joseph F. Gardocki Breakdown of academic impact, for papers by C. Guérémy Breakdown of academic impact, for papers by Stefanie A. Kane
Rankless by CCL
2026